Complete proteins from the cleanest eukaryotic expression platform—engineered yeast...
with YOU in mind.
Our engineered yeast platform secretes complex proteins with human post-translational modifications and complete folding for optimized bioactivity and stability. Our platform is efficient, simple, and engineered with YOU in mind. With ZERO dependency on animal origin inputs and ZERO endotoxin, our yeast platform is the cleanest approach to protein production.
Engineered yeast can express complete, complex proteins from a clean, animal-free expression platform.
Lorem ipsum dolor sit amet, ei vix mentitum sadipscing, mel latine tibique cu, ex nam magna habeo corrumpit. In eros probo ius, no quaerendum dissentiet theophrastus est, qui dolore detraxit cu. Agam pertinacia est an, veri iusto timeam duo ex. Prodesset mediocritatem te per, ei mea atqui nihil intellegam. Eu mea hinc cetero sanctus, option aperiri omnesque sea in, an eos suas enim.Lorem iusto id usu. At illum noster iriure est, malorum saperet an eum, pri an partem ridens. Ne ignota debitis vis, movet detracto accusata et quo. Vitae facete epicuri mea
Our engineering yeast cell lines have been engineered to secrete complete protein sequences that fold and behave as nature intended.
Human Post-Translational Modifications | Complete Folding | Optimized Reactivity | Better Value
The Simplicity and Elegance of Yeast
- BETTER PROTEIN STABILITY
Post translational modifications (PTMs) and chaperoned protein folding for proper 3D structure and better stability - MAXIUM BIOACTIVITY
Increased target cell signaling reactivity and folding induction - CLEANEST PLATFORM
Simple and scalable manufacturing process that does not require animal origin supplementation - SAFE EXPRESSION
Yeast cells, unlike bacterial expression systems, feature ZERO endotoxin or inclusion bodies and naturally secrete target proteins for simpler downstream processing
Engineered yeast can express complete, complex proteins from a clean, animal free expression platform
Human PTMs | Complete Folding | Optimized Reactivity | Better Value
Workflow Efficiency Diagram
A comprehensive kit containing core reprogramming and cell growth/culturing media and supplements designed to increase the efficiency of iPS cell reprogramming. This patented reprogramming method allows for a single transfection step, inherent clearance of exogenous episomal DNA during cell division versus repeated passaging when using Sendai virus methods, and no introduction of viral DNA and subsequent viral protein expression.
This kit requires a media change every 48 hours during reprogramming, saving researchers hands-on time and media consumption.
Applications & Technology
Lorem ipsum dolor sit amet, ei vix mentitum sadipscing, mel latine tibique cu, ex nam magna habeo corrumpit. In eros probo ius, no quaerendum dissentiet theophrastus est, qui dolore detraxit cu. Agam pertinacia est an, veri iusto timeam duo ex. Prodesset mediocritatem te per, ei mea atqui nihil intellegam. Eu mea hinc cetero sanctus, option aperiri omnesque sea in, an eos suas enim.Lorem iusto id usu. At illum noster iriure est, malorum saperet an eum, pri an partem
Our proprietary expression platforms produce human recombinant growth factor proteins to produce best-in-class biologics with fully native post-translational modification (PTM) and glycosylation profiles. Unlike proteins expressed from non- human E. coli and CHO-based systems, which are truncated to eliminate the glycosylated peptide sequence, our proteins reflect complete PTM profiles and glycosylation moieties that closely resemble proteins produced in utero. Our high- quality, cost-effective growth factors are designed to promote optimal cell differentiation while lowering overall workflow costs. Discover the performance benefits of growth factor proteins with human PTMs, correct folding structure, and optimal stability.
Our standard human recombinant growth factor portfolio can be customized further for your research and therapeutic development needs.
Our proprietary expression platforms produce human recombinant growth factor proteins to produce best-in-class biologics with fully native post-translational modification (PTM) and glycosylation profiles. Unlike proteins expressed from non- human E. coli and CHO-based systems, which are truncated to eliminate the glycosylated peptide sequence, our proteins reflect complete PTM profiles and glycosylation moieties that closely resemble proteins produced in utero. Our high- quality, cost-effective growth factors are designed to promote optimal cell differentiation while lowering overall workflow costs. Discover the performance benefits of growth factor proteins with human PTMs, correct folding structure, and optimal stability.
Our standard human recombinant growth factor portfolio can be customized further for your research and therapeutic development needs.
Our proprietary expression platforms produce human recombinant growth factor proteins to produce best-in-class biologics with fully native post-translational modification (PTM) and glycosylation profiles. Unlike proteins expressed from non-human E. coli and CHO-based systems, which are truncated to eliminate the glycosylated peptide sequence, our proteins reflect complete PTM profiles and glycosylation moieties that closely resemble proteins produced in utero.
Our high-quality, cost-effective growth factors are designed to promote optimal cell differentiation while lowering overall workflow costs. Discover the performance benefits of growth factor proteins with human PTMs, correct folding structure, and optimal stability.
Human Recombinant Growth Factors & Cytokines
